Analytical methods demonstrate how therapeutic interventions improve stability in colon cancer models, suggesting effective strategies for treatment.
Colon cancer is a high-risk malignant tumor worldwide. To address the limited efficacy and overlapping toxicity of current chemoimmunotherapy, this study establishes a fractional-order colon cancer model with a core architecture capturing the probiotics- CD4⁺ T cells-tumor cells axis. The primary theoretical contributions include: rigorous proof of solution existence and uniqueness through fixed-point theory. Analytical derivation of equilibrium stability conditions using the Routh-Hurwitz criterion. Numerical simulations systematically quantify how the fractional parameter α governs system dynamics and memory effects, while identifying critical drug dosage thresholds for tumor clearance. These findings provide a mathematical foundation for optimizing probiotic-based combination therapies.
No takes yet. Share an insight, caveat, or question.
Tai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: